The COVID-19 pandemic has highlighted how vulnerable and ill-prepared our healthcare systems are for dealing with pandemics on a global scale. The COVID-19 pandemic has highlighted the need to rapidly develop infrastructures (hospitals) to deal with infectious patients, shifting production lines rapidly to produce medical goods needed to contain the infection and treat infectious patients (including drugs). Add to this, delivering these items to locations that could provide the highest impact on the fight against the pandemic.